Myriad Genetics
MYGN
MYGN
239 hedge funds and large institutions have $2.12B invested in Myriad Genetics in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 88 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
5.97%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.12%
New
36
Increased
74
Reduced
88
Closed
30
Calls
$18.8M
Puts
$14.1M
Net Calls
+$4.69M
Net Calls Change
+$9.97M
Top Buyers
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
$70.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
$88.6M |
| 3 |
D.E. Shaw & Co
New York
|
$124M |
| 4 |
PP
PDT Partners
New York
|
$8.48M |
| 5 |
Northern Trust
Chicago,
Illinois
|
$33.4M |
